WHO vaccine-preventable diseases: monitoring system. 2018 global summary

Last updated 22-Oct-2018 (data as of 18-Sep-2018)
Next overall update spring 2019
EPI mother and child logo         
Select a country

Development status: Developed economy GNI / capita (US$): 14'7401 Infant (under 12 months) mortality rate: 42
GDP / capita (US$): 27'5981 Child (under 5 years) mortality rate: 52

Population data in thousands3

  2017  2016  2015  2014  2013  2000  1990  1980 
Total population 1'950  1'971  1'993  2'016  2'041  2'384  2'664  2'521 
Births 20  20  20  20  21  19  36  36 
Surviving infants 19  20  20  20  21  19  35  35 
Pop. less than 5 years 95  97  101  103  106  97  205  172 
Pop. less than 15 years 300  300  302  301  299  426  572  513 
Female 15-49 years 425  435  445  458  473  594  648  649 

Number of reported cases

(Click for retrospective incidence data for Latvia)
Diphtheria
ChartChart
  10  13  14  264 
Japanese encephalitis
 
Measles
ChartChart ChartChart
  36  21 
Mumps
ChartChart
  21  11  15  1'949 
Pertussis
ChartChart
  95  250  210  81  201  135  129 
Polio*
ChartChart
 
Rubella
ChartChart
  62 
Rubella (CRS)
ChartChart
 
Tetanus (neonatal)
ChartChart
 
Tetanus (total)**
ChartChart
 
Yellow fever
 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For disaggregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Latvia)
Vaccine year result method % card seen                                                
BCG 2013  97  EPI     96  96  94  92  94  99* 
DTP1          98  99  98  93  96  99* 
DTP3 2013  95  EPI     98  98  95  92  94  96 
DTP4          96  95  94  92 
IPV1          98  99  98  93 
HepB_BD          98 
HepB3 2013  95  EPI     98  98  94  92  94  95 
Hib3 2013  95  EPI     98  98  94  92  94  79 
JapEnc         
MCV1          96  93  96  95  96  97 
MCV2          89  89  92  89  92  90 
MenA         
PCV1          93  93  91  86  88 
PCV2          93  93  90  87  88 
PCV3 2013  83  EPI     87  82 
Pol3 2013  95  EPI     98  98  95  92  94  96 
Rota1          90  87  80 
RotaC          78  83  68 
RCV1          96  93  96  96  96 
TT2plus         
PAB         
VAD1         
YFV         
* indicates the country reported above 100% coverage.

  Next update: Mid July 2019

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Latvia)
BCG
ChartChart
  96  96  94  92  94  99 
DTP1
ChartChart
  98  99  98  93  96  99 
DTP3
ChartChart
  98  98  95  92  94  96 
HepB3
ChartChart
  98  98  94  92  94  95 
HepB_BD
ChartChart
  98 
Hib3
ChartChart
  98  98  94  92  94  79 
MCV1
ChartChart
  96  93  96  95  96  97 
MCV2
ChartChart
  89  89  92  89  92  90 
PCV3
ChartChart
  87  82  82  83  83 
Pol3
  98  98  95  92  94  96 
RCV1
ChartChart
  96  93  96  95  96  97 
RotaC
ChartChart
  78  83  68 

Click for WHO-UNICEF coverage estimates data for PAB time series.

Number of districts in the country 119  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 0
From 80 to 89% 0
From 50 to 79% 0
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
100
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2017 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG 2-5 days; Yes
DTaPHibHepBIPV 2, 4, 6, 12-15 months; Yes
DTaPHibIPV 2, 4, 6 months; Yes infants who receive hepB mono vaccine due to hepB risk exposure from monthers
DTaPIPV 7 years; Yes
HepB_Adult Yes for hemodialize patients
HepB_Pediatric birth; 1, 2, 12-15 months; Yes newborns with risk factors of hepB exposure from mothers (4 doses)
HPV 12 years (x2); Yes females only
Influenza_Adult >=65 years; Yes and adults with chronic illness, pregnant women, health care workers
Influenza_Pediatric 6-23 months; Yes and children with chronic illness
MMR 12-15 months; 7 years; Yes
Pneumo_conj 2, 4, 12-15 months; Yes
Rabies Yes after exposure with suspicious animals
Rotavirus 2, 4, 6 months; Yes
TBE 1-17 years (4); No (1) children living in highly endemic territories; (2) orphans and children left without parental care in the whole country
Td Yes adults
TdIPV 14 years; Yes
Varicella 12-15 months; 7 years; Yes from January 2019

Immunizaton indicators

Indicator Expected answer 2017  2016  2015  2014  2013  2012  2011 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  No 
What years does the MYP cover? number 2014-2020  2014-2020  2014-2020  2012-2014  2012-2014  2012-2014   
Nº of districts with microplans that include activities to raise immunization coverage number             NA 

System performance

Total Nº districts in country number 119  119  119  119  119  119  119 
Nº districts with DTP3 coverage >=80% number            
% of districts with DTP3 coverage >=80% From 0 to 100%            
Nº districts with measles (MCV1) coverage >=95% number        
% of districts with MCV1 coverage >=95% From 0 to 100%        

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND No  No  No  No  No  No  No 
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

% of Immunization expenditure financed, using Government funds? From 0 to 100% 100  100  100    91  100  100 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Sources

 1  "The 2017 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2018, data for 2016
 3  "United Nations, Population Division. The World Population Prospects - the 2017 revision". New York, 2017.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.